Fraunhofer and grit42 join forces in the global fight against antimicrobial resistance
Fraunhofer IME and grit42 are working together under the global umbrella of IMI’s AMR Accelerator. The combined efforts of Fraunhofer IME and grit42 is to facilitate a coherent and annotated data structure for the new IMI-backed project, Gram-Negative Antibacterials NOW (GNA NOW), which also focuses on AntiMicrobial Resistance (AMR).
The IMI-backed project ‘GNA NOW’ kicks off its battle against antimicrobial resistance
New partnership will advance three antibacterial programmes as part of the Innovative Medicines Initiative (IMI), a public-private European R&D consortium.